Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Collaboration    symbols : Dvax    save search

Valneva and IDT Biologika Agree on Termination of their COVID-19 Collaboration
Published: 2022-09-16 (Crawled : 21:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.5M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
IDT | $36.59 -1.03% 0.0% 53K twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

covid-19 valneva collaboration
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001
Published: 2021-11-29 (Crawled : 17:00) - globenewswire.com
IDT | $36.59 -1.03% 0.0% 53K twitter stocktwits trandingview |
Communications
| | O: 1.78% H: 0.0% C: -4.23%
DVAX | $11.42 -2.89% -2.98% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 2.82% H: 1.97% C: -4.23%

covid valneva vla200 collaboration vaccine vla2001 covid-19
Dynavax and U.S. Department of Defense Announce Collaboration to Develop an Adjuvanted Plague Vaccine Using Dynavax's CpG 1018 Adjuvant
Published: 2021-10-04 (Crawled : 13:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: -7.33% H: 3.22% C: 0.35%

defense collaboration vaccine yersinia pestis plague vaccine plague
Dynavax Provides Update on its COVID-19 Collaboration with Valneva
Published: 2021-09-13 (Crawled : 07:00) - prnewswire.com
DVAX | $11.42 -2.89% -2.98% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: -12.66% H: 2.16% C: -3.84%

covid collaboration covid-19
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
Published: 2020-07-16 (Crawled : 22:16) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 3.16% H: 1.8% C: -1.72%

collaboration vaccine influenza announces collaboration
Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
Published: 2020-07-23 (Crawled : 22:16) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 5.17% C: -1.27%

collaboration covid vaccine announces collaboration covid-19
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services

BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services

WHLM | $6.25 35.87% 28.46% 700K twitter stocktwits trandingview |
Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information


Your saved searches
Save your searches and get alerts when important news are released.